On the Anisotropic Milling Machinability of DD407 Single Crystal Nickel-Based Superalloy

The DD407 single crystal Ni-based superalloy with a face-centered cubic structure exhibits strong anisotropic characteristics. In order to reveal the material chip formation mechanism and the impact effect of crystal orientations on the materials’ milling machinability, a combination of experimental observations and theoretical analysis were applied in this study. Considering the resolved shear stress and slip system theories, a fundamental theoretical explanation of the milling force and surface quality along different crystal directions on the (001) crystal plane of the DD407 single crystal Ni-based superalloy was proposed based on a previously constructed anisotropic milling model. Our work in this research verifies that [110] crystal direction on the (001) crystal plane of the DD407 single crystal Ni-based superalloy is the most optimal feeding direction during milling, taking into account surface roughness and morphology, slot bottom plastic deformation, work hardening, and chip edge burr feature.     

Development and anti-Candida evaluation of the vaginal delivery system of amphotericin B nanosuspension-loaded thermogel

Vulvovaginal candidiasis (VVC) is a typical kind of vaginal mucosal infection. Herein, we developed a novel vaginal delivery system of amphotericin B (AmB) nanosuspension-loaded thermogel (AmB NPs/thermogel) utilising pharmaceutical technique of high-pressure homogenisation and Poloxamer P407/P188 hydrogel. The stabiliser and hydrogel materials of the formulation were tested to maintain proper sol–gel transition as well as the relative stability of the particle size of AmB nanosuspension in the thermogel. The particle size of AmB nanosuspensions in the hydrogel was ～247?nm. Transmission electron microscopy images confirmed the round-shape morphology of AmB nanoparticles in AmB NPs/thermogel, while that of irregular morphology of merely AmB nanosuspensions without stabiliser and hydrogel materials. AmB could be sustained release for ～12?h in vitro. In vivo drug content in the vaginal tissue was also evaluated with 87, 47, 33 and 6.7% drug remaining after 1, 3, 6 and 12?h, respectively. The in vivo anti-Candida test was conducted on candidiasis-infected mice model. In the same drug dose of 2.5?mg/kg, AmB NPs/thermogel showed better anti-Candida efficiency compared with commercial AmB effervescent tablet. This delivery system might show some insights for the vaginal formulation development of other hydrophobic antifungal drugs.     

Balancing the effect of corona on therapeutic efficacy and macrophage uptake of lipid nanocapsules

Several studies have shown the potential of biocompatible lipid nanocapsules as hydrophobic drug delivery systems. Understanding the factors that determine the interactions of these oil-in-water nanoemulsions with cells is a necessary step to guide the design of the most effective formulations. The aim of this study was to probe the ability of two surfactants with a markedly different nature, a non-ionic poloxamer, and a charged phospholipid, to prepare formulations with shells of different composition and different surface properties. Thus we determined their effects on the interaction with biological environments. In particular, we investigated how the shell formulation affected the adsorption of biomolecules from the surrounding biological fluids on the nanocapsule surface (corona formation). A complete physicochemical characterization including an isothermal titration calorimetry (ITC) study revealed that the use of poloxamer led to nanocapsules with a marked reduction in the number of protein-binding sites. Surface hydrophilicity and changes in corona formation strongly correlated to changes in uptake by cancer cells and by macrophages. Our results indicate that the nature and concentration of surfactants in the nanocapsules can be easily manipulated to effectively modulate their surface architecture with the aim of controlling the environmental interactions, thus optimizing functionality for in vivo applications. In particular, addition of surfactants that reduce protein binding can modulate nanoparticle clearance by the immune system, but also screens the desired interactions with cells, leading to lower uptake, thus lower therapeutic efficacy. The two effects need to be balanced in order to obtain successful formulations.     

Bundled postconditioning therapies improve hemodynamics and neurologic recovery after 17 min of untreated cardiac arrest

ObjectiveIschemic postconditioning (stutter CPR) and sevoflurane have been shown to mitigate the effects of reperfusion injury in cardiac tissue after 15 min of ventricular fibrillation (VF) cardiac arrest. Poloxamer 188 (P188) has also proven beneficial to neuronal and cardiac tissue during reperfusion injury in human and animal models. We hypothesized that the use of stutter CPR, sevoflurane, and P188 combined with standard advanced life support would improve post-resuscitation cardiac and neurologic function after prolonged VF arrest.MethodsFollowing 17 min of untreated VF, 20 pigs were randomized to Control treatment with active compression/decompression (ACD) CPR and impedance threshold device (ITD) (n = 8) or Bundle therapy with stutter ACD CPR + ITD + sevoflurane + P188 (n = 12). Epinephrine and post-resuscitation hypothermia were given in both groups per standard protocol. Animals that achieved return of spontaneous circulation (ROSC) were evaluated with echocardiography, biomarkers, and a blinded neurologic assessment with a cerebral performance category score.ResultsBundle therapy improved hemodynamics during resuscitation, reduced need for epinephrine and repeated defibrillation, reduced biomarkers of cardiac injury and end-organ dysfunction, and increased left ventricular ejection fraction compared to Controls. Bundle therapy also improved rates of ROSC (100% vs. 50%), freedom from major adverse events (50% vs. 0% at 48 h), and neurologic function (42% with mild or no neurologic deficit and 17% achieving normal function at 48 h).ConclusionsBundle therapy with a combination of stutter ACD CPR, ITD, sevoflurane, and P188 improved cardiac and neurologic function after 17 min of untreated cardiac arrest in pigs.All studies were performed with approval from the Institutional Animal Care Committee of the Minneapolis Medical Research Foundation (protocol #12-11).     

在人小肠上皮细胞膜上检出钙激活性钾通道(英文)

目的 :研究人类小肠上皮细胞 （Intestine40 7cell lines）膜上钙激活性钾通道的分子生物学特征及其电生理学特性。方法 :用 RT- PCR方法检测培养的人类小肠上皮细胞膜上钙激活性钾通道的表达形式 ,用膜片钳的全细胞记录及单通道记录法探讨了该通道的电生理学特点。结果 :RT- PCR证实该细胞系有 interm ediate- conductance（IK）钙激活性钾通道表达 ,而没有 large- conductance（BK）和 small- conductance（SK）钙激活性钾通道的表达。电生理学研究表明 ,Ionom ycin引导的全细胞电流显示该钙激活性钾电流具有内向整流性并可被特异度 IK钙激活性钾通道阻断剂 clotrimazole所抑制 ,但特异度 SK钙激活性钾通道阻断剂 apam in对该电流无明显抑制作用。单通道记录法证实该通道的电导为 30± 2 p S,通道活性对细胞内 Ca2 +浓度有明显依赖性。结论 :分子生物学和电生理研究证实了人类小肠上皮细胞膜上有 IK钙激活性钾通道 ,其生理学意义有待进一步研究     

Cardiorenal Syndrome and Heart Failure—Challenges and Opportunities

Cardiorenal syndromes (CRS) describe concomitant bidirectional dysfunction of the heart and kidneys in which 1 organ initiates, perpetuates, and/or accelerates decline of the other. CRS are common in heart failure and universally portend worsened prognosis. Despite this heavy disease burden, the appropriate diagnosis and classification of CRS remains problematic. In addition to the hemodynamic drivers of decreased renal perfusion and increased renal vein pressure, induction of the renin-angiotensin-aldosterone system, stimulation of the sympathetic nervous system, disruption of balance between nitric oxide and reactive oxygen species, and inflammation are implicated in the pathogenesis of CRS. Medical therapy of heart failure including renin-angiotensin-aldosterone system inhibition and β-adrenergic blockade can blunt these deleterious processes. Renovascular disease can accelerate the progression of CRS. Volume overload and diuretic resistance are common and complicate the management of CRS. In heart failure and CRS being treated with diuretics, worsening creatinine is not associated with worsened outcome if clinical decongestion is achieved. Adjunctive therapy is often required in the management of volume overload in CRS, but evidence for these therapies is limited. Anemia and iron deficiency are importantly associated with CRS and might amplify decline of cardiac and renal function. End-stage cardiac and/or renal disease represents an especially poor prognosis with limited therapeutic options. Overall, worsening renal function is associated with significantly increased mortality. Despite progress in the area of CRS, there are still multiple pathophysiological and clinical aspects of CRS that need further research to eventually develop effective therapeutic options.     

乌头碱温敏凝胶的制备及其体外评价

目的制备乌头碱温敏凝胶制剂,并对其体外释药进行考察。方法以温度敏感型材料泊洛沙姆407（P407）为载体材料制备乌头碱温敏凝胶制剂,通过正交设计优选出乌头碱温敏凝胶的处方工艺。采用恒温摇床法以磷酸盐缓冲液（pH=5.80）为释放介质测定其体外释放度。结果乌头碱温敏凝胶的胶凝温度为36.1℃。96 h体外累积释放率为89.45%。结论本实验制备工艺简单,制得的乌头碱温敏凝胶缓释性能良好,具有较好的应用前景。     

姜黄提取物固体分散体的制备及体外评价

目的 制备共聚维酮-泊洛沙姆姜黄提取物固体分散体[PVP/VA-Poloxamer-Curcumae Longae Rhizoma extract (CLRE)solid dispersion (SD),PAP-CSD]、共聚维酮姜黄提取物固体分散体(PVP/VA CLRE solid dispersion,PA-CS...